Introduction
RUNX3, a member of the RUNX family, plays a crucial role in regulating gene expression for cellular differentiation and cell cycle progression. It forms a heterodimer with its beta subunit, binding to the DNA sequence 5'-PYGPYGGT-3' found in enhancers and promoters. This complex can either activate or suppress transcription, interacting with other transcription factors. RUNX3's involvement in gastric cancer makes it a potential tumor suppressor diagnosis target.
Description
Recombinant Human RUNX3, produced in E. coli, is a single, non-glycosylated polypeptide chain comprising 155 amino acids (53-186 a.a.). With a molecular weight of 17.1 kDa, it features a 21 amino acid His-Tag fused at the N-terminus. Purification is achieved through proprietary chromatographic techniques.
Physical Appearance
Clear, colorless solution, sterile-filtered.
Formulation
RUNX3 Human solution (0.5mg/ml) in 20mM Tris-HCl buffer (pH 8.0), 20% glycerol, 0.1M NaCl, and 1mM DTT.
Stability
For short-term storage (2-4 weeks), refrigerate at 4°C. For longer periods, store frozen at -20°C. Adding a carrier protein (0.1% HSA or BSA) is recommended for long-term storage. Avoid repeated freeze-thaw cycles.
Purity
Purity exceeds 95.0% as determined by SDS-PAGE analysis.
Synonyms
AML2, CBFA3, PEBP2aC, PEBP2A3, FLJ34510, MGC16070, RUNX3, Oncogene AML-2, Runt-related transcription factor 3, Core-binding factor subunit alpha-3, Acute myeloid leukemia 2 protein, Polyomavirus enhancer-binding protein 2 alpha C subunit, SL3-3 enhancer factor 1 alpha C subunit, SL3/AKV core-binding factor alpha C subunit.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MRSMVDVLAD HAGELVRTDS PNFLCSVLPS HWRCNKTLPV AFKVVALGDV PDGTVVTVMA GNDENYSAEL RNASAVMKNQ VARFNDLRFV GRSGRGKSFT LTITVFTNPT QVATYHRAIK VTVDGPREPR RHRQK.